170 related articles for article (PubMed ID: 38032411)
1. Effect of GnRH agonist trigger with or without low-dose hCG on reproductive outcomes for PCOS women with freeze-all strategy: a propensity score matching study.
Wang Q; Wan Q; Li T; Wang X; Hu Y; Zhong Z; Pu K; Ding Y; Tang X
Arch Gynecol Obstet; 2024 Feb; 309(2):679-688. PubMed ID: 38032411
[TBL] [Abstract][Full Text] [Related]
2. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y
Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223
[TBL] [Abstract][Full Text] [Related]
3. GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.
O'Neill KE; Senapati S; Maina I; Gracia C; Dokras A
J Assist Reprod Genet; 2016 Sep; 33(9):1175-84. PubMed ID: 27349252
[TBL] [Abstract][Full Text] [Related]
4. Effect of GnRH agonist alone or combined with different low-dose hCG on cumulative live birth rate for high responders in GnRH antagonist cycles: a retrospective study.
He Y; Tang Y; Chen S; Liu J; Liu H
BMC Pregnancy Childbirth; 2022 Mar; 22(1):172. PubMed ID: 35236312
[TBL] [Abstract][Full Text] [Related]
5. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
[TBL] [Abstract][Full Text] [Related]
6. HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes.
Deepika K; Suvarna R; Sumi M; Snehal D; Arveen V; Anuja K; Gautham P; Kamini R
JBRA Assist Reprod; 2021 Feb; 25(1):48-58. PubMed ID: 32960521
[TBL] [Abstract][Full Text] [Related]
7. Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study.
Abdulkhalikova D; Bokal EV; Stimpfel M; Ciglar P; Korosec S
Front Endocrinol (Lausanne); 2022; 13():826411. PubMed ID: 35464066
[TBL] [Abstract][Full Text] [Related]
8. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
[TBL] [Abstract][Full Text] [Related]
10. Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching.
Dong L; Lian F; Wu H; Xiang S; Li Y; Wei C; Yu X; Xin X
BMC Pregnancy Childbirth; 2022 Jul; 22(1):583. PubMed ID: 35869444
[TBL] [Abstract][Full Text] [Related]
11. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
Orvieto R
J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
[TBL] [Abstract][Full Text] [Related]
12. Is oocyte maturity influenced by ovulation trigger type in oocyte donation cycles?
Jones BP; Al-Chami A; Gonzalez X; Arshad F; Green J; Bracewell-Milnes T; Saso S; Smith R; Serhal P; Ben Nagi J
Hum Fertil (Camb); 2021 Dec; 24(5):360-366. PubMed ID: 31571498
[TBL] [Abstract][Full Text] [Related]
13. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
Griffin D; Benadiva C; Kummer N; Budinetz T; Nulsen J; Engmann L
Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822
[TBL] [Abstract][Full Text] [Related]
14. Reproductive outcomes of dual trigger therapy with GnRH agonist and hCG versus hCG trigger in women with diminished ovarian reserve: a retrospective study.
Chen K; Zhang C; Chen L; Zhao Y; Li H
Reprod Biol Endocrinol; 2024 Apr; 22(1):35. PubMed ID: 38566172
[TBL] [Abstract][Full Text] [Related]
15. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
[TBL] [Abstract][Full Text] [Related]
16. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS.
Engmann L; Siano L; Schmidt D; Nulsen J; Maier D; Benadiva C
Reprod Biomed Online; 2006 Nov; 13(5):639-44. PubMed ID: 17169172
[TBL] [Abstract][Full Text] [Related]
17. Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials.
Hsia LH; Lee TH; Lin YH; Huang YY; Chang HJ; Liu YL
J Assist Reprod Genet; 2023 Sep; 40(9):2063-2077. PubMed ID: 37466846
[TBL] [Abstract][Full Text] [Related]
18. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
[TBL] [Abstract][Full Text] [Related]
19. GnRH triggering may improve euploidy and live birth rate in hyper-responders: a retrospective cohort study.
Tan J; Jing C; Zhang L; Lo J; Kan A; Nakhuda G
J Assist Reprod Genet; 2020 Aug; 37(8):1939-1948. PubMed ID: 32533431
[TBL] [Abstract][Full Text] [Related]
20. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
